The role of Mce proteins in Mycobacterium avium paratuberculosis infection

Rosemary Blake1, Kirsty Jensen2, Neil Mabbott2

  • 1The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK. rblake3@ed.ac.uk.

Scientific Reports
|June 28, 2024
PubMed

Insights

Mycobacterium avium subspecies paratuberculosis (MAP) uses effector molecules like Mce1A and Mce1D to adhere to and invade host cells. These proteins show cell-type specificity and enhance infection in intestinal models, offering potential therapeutic targets.

Area of Science:

  • Microbiology
  • Immunology
  • Veterinary Medicine

Background:

  • Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne's Disease in ruminants, a significant enteritis.
  • MAP infection initiates in the small intestine, requiring bacterial adhesion and internalization by host cells.
  • The specific MAP effector molecules mediating host cell interaction are not fully understood.

Purpose of the Study:

  • To investigate the role of specific Mycobacterium avium subspecies paratuberculosis (MAP) effector molecules in host cell interaction.
  • To characterize the function of MAP Mce1A, Mce1D, Mce3C, and Mce4A proteins in bacterial adhesion and invasion.
  • To assess the cell-type specificity and functional relevance of these MAP effector proteins in infection models.

Main Methods:

  • Expression of MAP Mce proteins (Mce1A, Mce1D, Mce3C, Mce4A) on the surface of non-invasive Escherichia coli.
  • Assessing E. coli attachment, intracellular survival, and invasion in human THP-1 and bovine MDBK cells.
  • Evaluating the infection capability of engineered E. coli in 3D bovine enteroid models.

Main Results:

  • Expression of Mce1A significantly enhanced E. coli attachment and intracellular survival in THP-1 cells.
  • Mce1D expression significantly increased E. coli attachment and invasion in MDBK cells, indicating cell-type specificity.
  • Both Mce1A and Mce1D on E. coli surface enhanced infection of 3D bovine enteroids.

Conclusions:

  • MAP utilizes effector molecules such as Mce1A and Mce1D for initial host interaction and invasion.
  • These MAP effector proteins exhibit cell-type specificity in their interactions with host intestinal cells.
  • The identified effector molecules represent potential targets for developing therapeutic interventions against Johne's Disease.